801 - 825 of 7916 Results
Title
Year
-
RESTRICTEDTitle: The Endo-lysosomal System in Parkinson’s Disease: Expanding the HorizonJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 168140End Page: 168140Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2023.168140Best OA location URL: https://doi.org/10.1016/j.jmb.2023.168140Citation Count: 9
-
OPENTitle: β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control StudyJournal Name: Clinical EpidemiologyPublisher: Informa UK LimitedVol: Volume 15Issue #:Start Page: 695End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/clep.s405325Best OA location URL: https://www.dovepress.com/getfile.php?fileID=90360Citation Count: 1
-
RESTRICTEDTitle: Bioinformatics pipeline to guide post‐GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variantsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 9Start Page: 4094End Page: 4109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.13168Citation Count: 1
- PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage2023OPENTitle: PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial DamageJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 66Issue #: 11Start Page: 7645End Page: 7656Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00555Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00555Citation Count: 7
-
OPENTitle: The contributions of mitochondrial and nuclear mitochondrial genetic variation to neuroticismJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-38480-yBest OA location URL: https://www.nature.com/articles/s41467-023-38480-y.pdfCitation Count: 2
-
OPENTitle: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1493End Page: 1502Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29450Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29450Citation Count: 16
- Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?2023RESTRICTEDTitle: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdfCitation Count: 5
- Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective2023RESTRICTEDTitle: Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging PerspectiveJournal Name: CellsPublisher: MDPI AGVol: 12Issue #: 11Start Page: 1469End Page: 1469Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells12111469Best OA location URL: https://www.mdpi.com/2073-4409/12/11/1469/pdf?version=1684979644Citation Count: 2
- Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkers2023OPENTitle: Methodological considerations in neuronal extracellular vesicle isolation for α-synuclein biomarkersJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 11Start Page: e95End Page: e97Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awad169Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad169/50433441/awad169.pdfCitation Count: 6
-
OPENTitle: Sex and Gender Influence Urinary Symptoms and Management in Multiple System AtrophyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 16Issue #: 2Start Page: 196End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.23016Best OA location URL: https://www.e-jmd.org/upload/jmd-23016.pdfCitation Count: 2
-
RESTRICTEDTitle: Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF PeriodsJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 12Issue #: 4Start Page: 1033End Page: 1049Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-023-00486-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-023-00486-5.pdfCitation Count: 2
-
OPENTitle: Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedoniaJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 10Start Page: 863End Page: 870Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2022-330790Best OA location URL: https://jnnp.bmj.com/content/jnnp/early/2023/05/25/jnnp-2022-330790.full.pdfCitation Count: 9
-
RESTRICTEDTitle: Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S MutationsJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1541End Page: 1545Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29449Citation Count: 4
-
OPENTitle: Association of sulfonylureas with the risk of dementia: A population‐based cohort studyJournal Name: Journal of the American Geriatrics SocietyPublisher: WileyVol: 71Issue #: 10Start Page: 3059End Page: 3070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jgs.18397Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgs.18397Citation Count: 13
- Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s disease2023OPENTitle: Estimated glomerular filtration rate is a biomarker of cognitive impairment in Parkinson’s diseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2023.1130833Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2023.1130833/pdfCitation Count: 4
-
RESTRICTEDTitle: Brain Calcifications: Genetic, Molecular, and Clinical AspectsJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 10Start Page: 8995End Page: 8995Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms24108995Best OA location URL: https://www.mdpi.com/1422-0067/24/10/8995/pdf?version=1684484473Citation Count: 3
-
OPENTitle: Dopaminergic Dysfunction Is More Symmetric in Dementia with Lewy Bodies Compared to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 13Issue #: 4Start Page: 515End Page: 523Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-230001Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230001?id=journal-of-parkinsons-disease%2Fjpd230001Citation Count: 12
-
OPENTitle: Status of Current Biofluid Biomarkers in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13753Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13753Citation Count: 2
-
OPENTitle: Association of Cortical and Subcortical Microstructure With Clinical Progression and Fluid Biomarkers in Patients With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 101Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000207408Citation Count: 7
-
OPENTitle: Assortative mixing in micro-architecturally annotated brain connectomesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-38585-4Best OA location URL: https://www.nature.com/articles/s41467-023-38585-4.pdfCitation Count: 12
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 15
-
OPENTitle: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 146Issue #: 1Start Page: 51End Page: 75Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-023-02585-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-023-02585-x.pdfCitation Count: 11
-
RESTRICTEDTitle: Valbenazine as treatment for Huntington's disease choreaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 6Start Page: 459End Page: 460Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00163-1Citation Count: 3
-
OPENTitle: Biologic targets of prescription medications and risk of neurodegenerative disease in United States Medicare beneficiariesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 5Start Page: e0285011End Page: e0285011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0285011Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0285011&type=printableCitation Count: 1
-
OPENTitle: Generation of gene-corrected isogenic controls from Parkinson's disease patient iPSC lines carrying the pathogenic SNCA p.A53T variantJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103125End Page: 103125Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2023.103125Best OA location URL: https://doi.org/10.1016/j.scr.2023.103125Citation Count: 1